Maxim Group Maintains Buy on Cryo-Cell International, Lowers Price Target to $8.5
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Maxim Group analyst Allen Klee maintains Cryo-Cell International (AMEX:CCEL) with a Buy and lowers the price target from $9 to $8.5.
Maxim Group analyst Allen Klee maintains Cryo-Cell International (AMEX:CCEL) with a Buy and lowers the price target from $9 to $8.5.